PMID: 8450299Mar 1, 1993Paper

Antiphospholipid antibodies and ischaemic heart disease

Journal of Internal Medicine
P Jørgensen, P R Hansen

Abstract

Antiphospholipid antibodies (APA) have been detected in various conditions including venous and arterial thrombosis, recurrent fetal loss, thrombocytopenia and cardiac valvular lesions. APA were initially found in patients with systemic lupus erythematosus (SLE) but later have been demonstrated also in patients without connective tissue disease. We report the extensive evaluation of a 24-year-old otherwise healthy male with APA and a family history of SLE who presented with severe ischaemic heart disease requiring coronary by-pass surgery.

References

Feb 1, 1990·Immunology Today·C Mackworth-Young
Apr 1, 1990·The American Journal of Cardiology·R De CaterinaS Bombardieri
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H P McNeilS A Krilis
Aug 1, 1989·Australian and New Zealand Journal of Medicine·P RallingsR Abraham
Jul 1, 1989·British Heart Journal·J J Murphy, I H Leach
Dec 13, 1986·Lancet·K E MortonC N Chesterman
Dec 1, 1985·Annals of the Rheumatic Diseases·R A AshersonG R Hughes
Apr 1, 1980·Australian and New Zealand Journal of Medicine·L P BignoldH Kronenberg

❮ Previous
Next ❯

Citations

Nov 5, 2010·Journal of Cardiothoracic Surgery·Ioanna KoniariEfstratios Apostolakis
Jan 26, 1999·Clinics in Chest Medicine·M J Longo, M S Remetz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.